Celltrion
068270.KS
#785
Rank
โ‚น2.780 T
Marketcap
โ‚น12,711
Share price
-0.24%
Change (1 day)
17.51%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2025 (TTM): โ‚น59.16 Billion

According to Celltrion 's latest financial reports the company's current earnings are โ‚น2.74 Billion. In 2024 the company made an earning of โ‚น43.18 Billion a decrease over its 2023 earnings that were of โ‚น47.40 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น59.16 B36.99%
2024 โ‚น43.18 B-8.89%
2023 โ‚น47.40 B6.61%
2022 โ‚น44.46 B-21.93%
2021 โ‚น56.95 B10.28%
2020 โ‚น51.64 B65.38%
2019 โ‚น31.22 B16.74%
2018 โ‚น26.74 B-33.93%
2017 โ‚น40.48 B106.65%
2016 โ‚น19.59 B25.18%
2015 โ‚น15.65 B-6.4%
2014 โ‚น16.72 B47.49%
2013 โ‚น11.33 B-33.58%
2012 โ‚น17.06 B
2010 โ‚น8.88 B72.52%
2009 โ‚น5.14 B258.3%
2008 โ‚น1.43 B